This disclosure relates to new compounds that may be used to modulate a histamine receptor in an individual. Novel compounds are described, including new bridged heterocyclic [4,3-b]indole compounds. Pharmaceutical compositions are also provided. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
US9051314B2
申请人:——
公开号:US9051314B2
公开(公告)日:2015-06-09
411. Some derivatives of diphenylamine and a new synthesis of N-arylanthranilic acids and of acridones